We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$28.2B
1-Year Est. Return
115.26%
This Fund
S&P 500
This Quarter
Est. Return
+12.57%
1 Year Est. Return
+115.26%
3 Year Est. Return
+356.87%
5 Year Est. Return
+474.2%
10 Year Est. Return
–
AUM
$23M
AUM Growth
-$16.1B
(-100%)
Cap. Flow
+$565M
Cap. Flow
% of AUM
2,455.36%
Top 10 Holdings %
Top 10 Hldgs %
41.7%
Holding
389
New
66
Increased
150
Reduced
80
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$194M |
| 2 |
Advanced Micro Devices
AMD
|
+$148M |
| 3 |
Seagate
STX
|
+$130M |
| 4 |
Meta Platforms (Facebook)
META
|
+$124M |
| 5 |
CrowdStrike
CRWD
|
+$99.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$178M |
| 2 |
Alibaba
BABA
|
+$163M |
| 3 |
Analog Devices
ADI
|
+$161M |
| 4 |
Uber
UBER
|
+$133M |
| 5 |
Cadence Design Systems
CDNS
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.28% |
| 2 | Industrials | 21.32% |
| 3 | Healthcare | 15% |
| 4 | Communication Services | 12.09% |
| 5 | Financials | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
HealthEquity
HQY
$8.75B
| $715 | ﹤0.01% |
8,879
+3,198
| +56% | +$244K |
|
302
Bruker
BRKR
$8.14B
| $704 | ﹤0.01% |
9,265
-13,524
| -59% | -$944K |
|
303
Medpace
MEDP
$16.5B
| $670 | ﹤0.01% |
3,795
-3,389
| -47% | -$585K |
|
304
OptimizeRx
OPRX
$133M
| $629 | ﹤0.01% |
+10,168
| New | +$517K |
|
305
Establishment Labs
ESTA
$2.28B
| $556 | ﹤0.01% |
6,367
| – | – |
|
306
Vericel Corp
VCEL
$2.31B
| $552 | ﹤0.01% |
+10,515
| New | +$599K |
|
307
Progyny
PGNY
$2.2B
| $544 | ﹤0.01% |
9,223
| – | – |
|
308
iQIYI
IQ
$1.28B
| $539 | ﹤0.01% |
34,590
+479
| +1% | +$7.13K |
|
309
Lantheus
LNTH
$6.59B
| $539 | ﹤0.01% |
+19,504
| New | +$448K |
|
310
Ocular Therapeutix
OCUL
$2.02B
| $536 | ﹤0.01% |
37,790
+10,251
| +37% | +$156K |
|
|
SCTL
311
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $513 | ﹤0.01% |
+222,222
| New | +$564K |
|
|
SWAV
312
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $438 | ﹤0.01% |
+2,310
| New | +$378K |
|
313
HDFC Bank
HDB
$121B
| $403 | ﹤0.01% |
11,018
+1,152
| +12% | +$42.2K |
|
|
IMDX
314
Insight Molecular Diagnostics
IMDX
$156M
| $382 | ﹤0.01% |
3,326
| – | – |
|
|
CBAY
315
DELISTED
Cymabay Therapeutics
CBAY
| $356 | ﹤0.01% |
81,630
+25,000
| +44% | +$111K |
|
|
CFLT
316
DELISTED
Confluent
CFLT
| $238 | ﹤0.01% |
+5,000
| New | +$242K |
|
|
XENT
317
DELISTED
Intersect ENT, Inc
XENT
| $220 | ﹤0.01% |
12,856
| – | – |
|
|
TRVN
318
DELISTED
Trevena, Inc.
TRVN
| $181 | ﹤0.01% |
171
| – | – |
|
|
TMPOW
319
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
| $149 | ﹤0.01% |
+15,000
| New | +$29.2K |
|
|
FENG
320
Phoenix New Media
FENG
$18M
| $143 | ﹤0.01% |
15,325
+6,194
| +68% | +$61.6K |
|
321
Acadia Pharmaceuticals
ACAD
$5.03B
| – | – |
-60,879
| Closed | -$1.57M |
|
322
Autodesk
ADSK
$52.6B
| – | – |
-22,477
| Closed | -$6.23M |
|
323
Afya
AFYA
$1.27B
| – | – |
-201,527
| Closed | -$3.75M |
|
324
AdaptHealth
AHCO
$759M
| – | – |
-1,913,917
| Closed | -$70.4M |
|
325
Ascendis Pharma A/S
ASND
$16.8B
| – | – |
-2,524
| Closed | -$325K |
|
Similar funds
N
TWC
FDCDDQ
NA
Polar Capital Holdings's Q2 2021 Portfolio in Review
As of Q2 2021, Polar Capital Holdings held 389 positions worth $23M, down 100% from $16.2B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Polar Capital Holdings deployed $565M of net new capital in Q2 2021, opening 66 new positions and adding to 150 existing holdings. Its largest new stake was Marvell Technology: 3,975,034 shares worth $232K.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Visa, an estimated $178M trimmed.
- Polar Capital Holdings's largest Q2 2021 buy was Marvell Technology: 3,975,034 shares worth $232K.
- Polar Capital Holdings added most to Advanced Micro Devices in Q2 2021, an estimated $148M increase.
- Polar Capital Holdings's biggest Q2 2021 reduction was Visa, cutting an estimated $178M.
- Polar Capital Holdings fully exited Cadence Design Systems in Q2 2021, selling an estimated $129M.
- Polar Capital Holdings's ten largest holdings make up 42% of its $23M portfolio in Q2 2021.
- Polar Capital Holdings opened 66 new positions and closed 39 in Q2 2021.
- Polar Capital Holdings's portfolio value fell 100% quarter-over-quarter to $23M.
Based on Polar Capital Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.